Evidence map›Paper›PMID 41463259›Full record

ArticleCancers2025

Comparative Analysis of Bone Marrow, cfDNA and CTCs for NGS-Based Multiple Myeloma Detection: A Pilot Study Indicating the Potential of CTCs.

Wouter De Brouwer, Robbe Heestermans, Jona Van der Straeten, Kiara Falise, Ann De Becker, Isabelle Vande Broek, Rik Schots, Marleen Bakkus, Ivan Van Riet

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wouter De BrouwerResearch Group Hematology-Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.
Robbe HeestermansResearch Group Hematology-Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.ORCID 0000-0003-2937-1705
Jona Van der StraetenResearch Group Hematology-Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.ORCID 0000-0002-0611-0687
Kiara FaliseResearch Group Hematology-Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.
Ann De BeckerResearch Group Hematology-Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.ORCID 0000-0003-0947-8708
Isabelle Vande BroekDepartment of Hematology, VITAZ, Moerlandstraat 1, 9100 Sint-Niklaas, Belgium.ORCID 0009-0003-7923-7149
Rik SchotsResearch Group Hematology-Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.
Marleen BakkusResearch Group Hematology-Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.ORCID 0000-0002-0863-3369
Ivan Van RietResearch Group Hematology-Immunology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.ORCID 0000-0002-3662-4347

Funding

Kom op tegen kanker no number
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell free DNAcirculating tumor cellsliquid biopsyminimal residual diseasemultiple myeloma

Identifiers

PMID41463259
PMCPMC12730876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.